CBLL NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

CeriBell, Inc · Healthcare · Medical Devices

Open interactive chart View report data Download investor PDF
Latest close 16.91 USD
-9.7% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -13.1% below the Trend Line and sits at 45.0% of its 52-week range. The latest completed week returned -9.7%, after a -15.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 5d.

Setup score 26 out of 100
Latest Close 16.91 USD 24 Jul 2026
1W Return -9.7% latest completed week
4W Return -15.4% short-term follow-through
12W Return -17.5% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -9.7% Latest completed week; four-week move -15.4%. Indicator stack 22/43 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 59/100 conviction; expected move 20.0%. News sentiment 49/100 29 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -13.1% below the Trend Line and sits at 45.0% of its 52-week range. The latest completed week returned -9.7%, after a -15.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2912-week average 0.39

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.29Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -15.4% over four weeks, -17.5% over 12 weeks, and 11.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-9.7%
4W-15.4%
12W-17.5%
26W-24.2%
52W11.8%
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.32Latest activity-pressure read.
Pressure change-18.2%Four-week change in activity pressure.
Leadership-9.63Latest relative-leadership reading.
RS change-478.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value20/100Relative valuation strength. Underlying universe rank 81; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum69/100Medium-term price momentum. Underlying universe rank 32; rank 1 is best.
Growth84/100Revenue and earnings growth. Underlying universe rank 17; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
6.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-7.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
87.7%
Gross profit retained from each unit of revenue.
Operating margin
-61.6%
Operating profit retained from revenue.
Free-cash-flow margin
-49.7%
Free cash flow generated from revenue.
Return on invested capital
-37.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
33.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-1.1%
Net share repurchases relative to market value.
Shareholder yield
-1.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CBLL shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 40.00, expected move of 20.0%, and Sharemaestro trend signal inactive.

Conviction59/100
Expected move20.0%
Put/call volume40.00
Pressure-86
Speculation11
Volatility96
Trend agreement41
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 29 relevant articles.

2 positive · 25 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move20.0%Nearest-chain priced movement where available.
52-week drawdown-30.5%Distance below the 52-week high.
13-week volatility8.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+16.7%Week of 17 Apr.
Worst week-19.3%Week of 15 May.
Latest week-9.7%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains5
Flat weeks0
Modest losses11
Sharp losses6
Recent vol8.0%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis21/100

Latest 12-week confirmation: trend 2/12, activity pressure 1/12, relative leadership 1/12.

Activity pressure 0.29; No reversal markers Factors24/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 77; Small Cap Core rank 85 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options49/100

CBLL shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 40.00, expected move of 20.0%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 20.0% Sentiment49/100

Weighted news tone is neutral across 29 relevant articles.

CeriBell, Inc. Revenue Breakdown – NASDAQ:CBLL Insiders50/100

No recent insider transaction evidence is stored.

 Earnings5d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202616.91 USD-9.7%19.46 USD19.09 USD-0.32-9.631.8MOff
17 Jul 202618.72 USD-4.3%19.60 USD19.11 USD0.04-1.701.8MOff
10 Jul 202619.56 USD0.1%19.68 USD19.12 USD-0.03-1.631.4MOff
3 Jul 202619.55 USD-2.2%19.73 USD19.11 USD-0.13-0.051.8MOff
26 Jun 202619.98 USD10.8%19.74 USD19.11 USD-0.272.542.5MOff
19 Jun 202618.03 USD-2.4%19.64 USD19.10 USD-0.52-12.021.6MOff
12 Jun 202618.47 USD1.2%19.54 USD19.11 USD-0.43-8.091.4MOff
5 Jun 202618.25 USD-1.1%19.36 USD19.12 USD-0.47-7.551.5MOff
29 May 202618.45 USD-1.7%19.15 USD19.13 USD-0.38-11.23648.5KOff
22 May 202618.77 USD15.2%18.91 USD19.13 USD-0.27-7.551.7MOff
15 May 202616.30 USD-19.3%18.72 USD19.14 USD-0.30-19.103.0MOn
8 May 202620.20 USD-1.5%18.60 USD19.17 USD-0.25-0.851.3MOn
1 May 202620.50 USD-3.2%18.32 USD19.16 USD-0.445.841.3MOn
24 Apr 202621.18 USD-0.0%18.06 USD19.14 USD-0.5810.811.0MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.